查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1466340

組織診斷市場：按產品、技術、適應症和最終用戶分類 - 全球預測 2024-2030

Tissue Diagnostics Market by Product (Accessories, Consumables, Instruments), Technology (Digital Pathology & Workflow, Immunohistochemistry, In Situ Hybridization), Indications, End-User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年組織診斷市場規模為83億美元，2024年將達89.4億美元，2030年將達140.2億美元，複合年成長率為7.76%。

組織診斷是一個醫學領域，透過測試和分析從患者體內採集的組織樣本來診斷疾病和狀況。它對於各種醫療狀況的診斷和治療極為重要，包括癌症和其他組織相關疾病。組織診斷劑應用於多個臨床領域，在有助於疾病早期檢測的個人化醫療中極為重要。全球癌症發生率上升和人口老化正在推動對組織診斷服務的需求。基因組學的進步導致了許多與疾病相關的生物標記的鑑定，進一步增加了對準確診斷測試的需求。然而，與診斷設備和服務相關的高成本可能會阻礙小型醫療保健提供者和資源匱乏的環境的採用。由於缺乏能夠解釋複雜測試結果的熟練專業人員以及全球病理學家的短缺，市場擴張也可能受到阻礙。人工智慧 (AI) 與數位病理學的整合等技術進步正在為市場參與者創造新的機會。基於人工智慧的演算法可以幫助病理學家檢測組織內容易被忽略的細微型態變化。此外，政府和私人組織對醫療保健基礎設施投資的增加預計將進一步為該行業的成長鋪平道路。

主要市場統計
基準年[2023] 83億美元
預測年份 [2024] 89.4億美元
預測年份 [2030] 140.2億美元
複合年成長率（%） 7.76%

擴大組織處理系統的使用，以有效地處理和分析產品組織樣本

配件透過補充設備和耗材的功能，對於確保準確的組織診斷至關重要。配件通常是指與初級組織診斷儀器和設備一起使用的各種輔助產品和組件。這些配件可提高組織診斷工具和設備的效能、效率和功能。耗材可檢測組織樣本製備、染色、分析和儲存各個步驟所必需的特定生物標記。它對於組織診斷實驗室的日常業務至關重要。組織診斷市場包括用於收集、處理、分析和診斷組織樣本的各種儀器和設備。這些儀器對於準確評估組織標本至關重要，並在病理學、組織學和臨床診斷等領域發揮重要作用。組織學診斷軟體解決方案可以處理、儲存和分析從掃描載玻片獲得的數位影像。機器學習演算法和人工智慧正在用於診斷程序，以促進病理學家之間的遠端諮詢。這些先進技術提供更準確和精確的診斷，確保改善患者照護和治療結果。

技術 採用數位病理技術，利用電腦技術管理數位化組織學樣本

數位病理學使用電腦技術來管理數位化組織學樣本產生的資訊。數位病理系統可實現數位切片的高效診斷、解釋、影像分析、儲存和共用。它提高的準確性和縮短的周轉時間使其成為世界各地病理學家的重要工具。免疫組織化學（IHC）是一種利用酵素標記抗體作為標記物，透過抗原抗體交互作用來檢測組織樣本中特定蛋白質的方法。此方法透過識別與癌細胞和周圍組織相關的特異性生物標記物，在癌症等各種疾病的診斷中發揮重要作用。原位雜合技術 (ISH) 是一種檢測組織樣本細胞內特定 RNA 或 DNA 序列的技術。此方法可用於評估基因表現模式、染色體畸變和拷貝數變化。螢光原位雜合反應利用螢光探針進行檢測。特殊的染色技術可視化特定的細胞成分或突出組織學樣本中的特定結構。 IHC 和 ISH 對於了解組織的分子特性和檢測特異性生物標記至關重要。特殊的染色技術提供了使用傳統方法無法看到的細胞結構的額外洞察。

適應症：組織診斷劑在多種癌症類型的檢測和表徵中的快速普及

組織診斷在乳癌的早期檢測和表徵中發揮著至關重要的作用，從而實現個人化治療以改善患者預後。免疫組織化學 (IHC) 和螢光原位雜合反應(FISH) 等技術廣泛用於識別荷爾蒙受體狀態，指導標靶治療決策。使用組織學診斷劑鑑定胃癌的不同亞型有助於臨床醫生預測預後並選擇治療方法。 IHC 通常用於檢測 HER2 過度表達等分子生物標記，並指導曲妥珠單抗等標靶治療的使用。由於淋巴瘤是一組涉及免疫系統細胞的異質性惡性，因此準確的診斷和分型對於適當的治療計劃至關重要。組織學診斷技術可以識別特異性的細胞標記以區分何傑金氏淋巴瘤和非何傑金氏淋巴瘤，甚至可以識別這些類別中的亞型。組織診斷可以幫助識別 EGFR 突變、ALK 重排和 PD-L1 表達水平等基因變化，以指南治療決策。攝護腺癌是全世界男性第二常見的癌症。組織學診斷劑對於使用格里森評分來確定腫瘤的病理惡性以及評估 Ki-67 和 PTEN 缺乏等預後標記極為重要。

最終使用者：在臨床病理實驗室中使用組織診斷可以提高病患照護的品質。

臨床病理實驗室對組織診斷試劑的主要需求是在分子層面檢測和診斷各種疾病。免疫組織化學 (IHC)、原位雜合反應(ISH) 和蘇木精 (H&E) 染色等技術可以幫助病理學家識別與特定疾病相關的生物標記。委外研發機構(CRO) 需要為製藥和生物技術公司提供臨床前和臨床試驗的研究服務。這些組織在選擇組織診斷解決方案時優先考慮成本效益、擴充性和周轉時間。組織診斷對於醫院的患者診斷、治療選擇和疾病監測至關重要。醫院需要可靠的診斷解決方案，在最短的周轉時間內提供準確的結果，以提高患者照護質量，同時最大限度地降低成本。製藥公司需要解決方案來利用組織診斷進行藥物開發和臨床試驗、確定精準醫療的目標族群、最佳化患者分層並即時評估治療反應。學術和研究機構需要尖端的組織診斷解決方案來研究疾病機制、發現新的生物標記並推進治療開發。這些研究機構更喜歡支持高通量分析和多重功能的創新技術。

區域洞察

由於先進的醫療基礎設施和領先製造商為診斷測試開發提供的大量研究資金，美洲在市場格局中佔據重要地位。該地區的製造商因組織診斷技術的創新而獲得了 FDA 頒發的多項專利。在歐洲、中東和非洲地區，組織診斷市場將呈現新興市場的面貌，因為各國政府正在大力投資以改善診斷技術並支持癌症等疾病早期診斷的研究和開發。有關組織診斷耗材安全和品質的政府標準和法規也促進了該地區的市場成長。南非是非洲大陸的創新中心，正在進行多項研究舉措，重點是開發有效的診斷工具，以應對當地疾病的爆發模式。新興市場 由於技術進步、對尖端組織診斷技術研發的投資、癌症發病率的增加以及政府鼓勵本地生產診斷設備和促進國家創新的努力，亞太地區正在成為一個新興市場。

FPNV定位矩陣

FPNV 定位矩陣對於評估組織診斷市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標，以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估，供應商被分為四個成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對組織診斷市場供應商的現狀進行深入而深入的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻，以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外，該分析還提供了對該行業競爭特徵的寶貴見解，包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略，從而在市場上獲得競爭優勢。

本報告對以下幾個方面提供了寶貴的見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開拓：我們深入研究利潤豐厚的新興市場，並分析其在成熟細分市場的滲透率。

3. 市場多元化：提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4.競爭評估與資訊：對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況、製造能力等進行全面評估。

5. 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告解決了以下關鍵問題：

1.組織診斷市場的市場規模與預測為何？

2.在組織診斷市場的預測期間內，有哪些產品、細分市場、應用和領域需要考慮投資？

3.組織診斷市場的技術趨勢和法規結構是什麼？

4.組織診斷市場主要廠商的市場佔有率為何？

5.進入組織診斷市場合適的型態和策略手段是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 全球癌症發生率增加
      • 擴大個人化醫療的使用
      • 政府努力提高人們對有效早期癌症診斷的認知
    • 抑制因素
      • 組織診斷的高成本和報銷問題
    • 機會
      • 數位病理學和自動化的開始 組織診斷藥物
      • 組織診斷領域創新技術與設備開發
    • 任務
      • 與組織診斷程序相關的限制和隱私問題
  • 市場區隔分析
    • 產品：組織處理系統的普及，用於診斷組織樣本的高效處理和分析
    • 技術：採用數位病理技術，透過電腦技術對數位化組織學樣本進行管理
    • 適應症：組織診斷在多種癌症類型的檢測和表徵中的指數級應用
    • 最終用戶：利用臨床病理實驗室的組織診斷來提高患者照護質量
  • 市場趨勢分析
    • 專注於獲得美洲組織診斷技術的核准
    • 政府推動亞太地區慢性病早期發現和篩檢的舉措
    • 歐洲、中東和非洲地區組織診斷技術的革命性進展
  • 俄羅斯-烏克蘭衝突的累積影響
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法規結構分析

第6章組織診斷市場：依產品

  • 配件
  • 消耗品
  • 裝置
  • 軟體

第7章組織診斷市場：依技術分類

  • 數位病理學和工作流程
  • 免疫組織化學
  • 原位雜合技術
  • 特殊染色

第8章按適應症分類的組織學診斷市場

  • 乳癌
  • 胃癌
  • 淋巴瘤
  • 非小細胞肺癌
  • 攝護腺癌

第9章組織診斷市場：依最終使用者分類

  • 臨床病理學
  • 合約調查機構
  • 醫院
  • 製藥機構
  • 研究室

第10章美洲的組織診斷市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太組織診斷市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲的組織診斷市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭場景分析
    • PathAI 宣布擴建生物製藥實驗室，提供端對端中央病理學和組織學服務
    • Ibex 籌集了 5,500 萬美元的 C 系列資金籌措，以推動人工智慧在癌症診斷領域的全球應用
    • Quest Diagnostics 推出新的前列腺癌檢測以改善診斷和分級
    • Cythelabs 將診斷服務擴展到印度南部的醫院和患者
    • Biotechne 收購 Lunaphor 以透過空間生物學加強癌症診斷
    • Lunaphore 獲得 4000 萬瑞士法郎以加強組織診斷解決方案組合
    • 推出免疫組織化學新試劑解決方案“Optimer-Fc”
    • Ibex 和 Albano Laboratories 簽署癌症診斷人工智慧的多年、多組織擴展協議
    • 羅氏擴大與楊森的合作，透過伴同性診斷推進個人化醫療保健
    • Guardant Health 將 Lunit 基於 AI 的 Pd-L1 評分演算法整合到產品組合中，以增強癌症生物標記檢測
    • Epredia 和 Aiforia 加入 RegenMed Hub 創新加速器，合作夥伴關係擴大了 PHC 集團在再生醫學領域的影響力，為新的 RegenMed 臨床試驗催化劑計劃鋪平了道路
    • 微軟與 Page 合作推動癌症診斷和治療
    • 安捷倫和 Akoya Biosciences 宣布合作推動生物製藥應用多重組織檢測開發
    • Tempus 其基於 NGS 的體外診斷設備 xT CDx 獲得美國FDA核准
    • 羅氏組織診斷慶祝 Marana 擴建計劃

第14章競爭產品組合

  • 主要企業簡介
  • 主要產品系列
Product Code: MRR-03142C0401D5

[196 Pages Report] The Tissue Diagnostics Market size was estimated at USD 8.30 billion in 2023 and expected to reach USD 8.94 billion in 2024, at a CAGR 7.76% to reach USD 14.02 billion by 2030.

Tissue diagnostics is a medical field that involves examining and analyzing tissue samples from a patient's body to diagnose diseases or conditions. It is crucial in diagnosing and treating various medical conditions, including cancer and other tissue-related diseases. Tissue diagnostics has applications across several clinical areas and is crucial in personalized medicine for assisting in early disease detection. An increase in global cancer prevalence rates and an aging population drive the demand for tissue diagnostic services. Advancements in genomics have led to the identification of numerous biomarkers associated with diseases, which have further spurred the need for accurate diagnostic tests. However, high costs associated with diagnostic instruments and services might impede their adoption by small-scale healthcare providers or low-resource settings. The lack of skilled professionals capable of interpreting complex test results and insufficient pathologists worldwide could hinder market expansion. Technological advances such as artificial intelligence (AI) integration with digital pathology have opened up new opportunities for the market players. AI-based algorithms can aid pathologists in detecting subtle morphological changes within tissues that may be easily overlooked. Additionally, growing investments from governments and private organizations towards healthcare infrastructure are expected to provide more avenues for growth in this sector.

KEY MARKET STATISTICS
Base Year [2023] USD 8.30 billion
Estimated Year [2024] USD 8.94 billion
Forecast Year [2030] USD 14.02 billion
CAGR (%) 7.76%

Product: Proliferating use of tissue-processing systems for efficient processing and analyzing diagnosing tissue samples

Accessories are crucial in ensuring precise tissue diagnosis by complementing the function of instruments and consumables. Accessories typically refer to a wide range of supplementary products and components used with the primary tissue diagnostic instruments and equipment. These accessories enhance tissue diagnostic tools and devices' performance, efficiency, and functionality. Consumable products detect specific biomarkers essential for various steps in tissue sample preparation, staining, analysis, and storage. They are integral to the day-to-day operations of tissue diagnostic laboratories. The tissue diagnostics market encompasses various instruments and equipment for collecting, processing, analyzing, and diagnosing tissue samples. These instruments are essential for accurately assessing tissue specimens and play a crucial role in fields such as pathology, histology, and clinical diagnostics. Tissue diagnostic software solutions enable the processing, storing, and analyzing digital images obtained from scanned slides. Machine learning algorithms and artificial intelligence are utilized in diagnostics programs to facilitate remote consultations between pathologists. These advanced technologies provide more accurate and precise diagnoses, ensuring enhanced patient care and treatment outcomes.

Technology: Adoption of digital pathology technology for the management of digitized histological samples through computer technology

Digital pathology uses computer technology to manage information generated from digitized histological samples. Digital pathology systems enable efficient diagnosis, interpretation, image analysis, storage, and sharing of digital slides. The increased accuracy and reduced turnaround time make it an essential tool for pathologists worldwide. Immunohistochemistry (IHC) is a method utilized to detect specific proteins in tissue samples through antigen-antibody interactions using enzyme-labeled antibodies as markers. This method plays a vital role in diagnosing various diseases, such as cancer, by identifying specific biomarkers associated with tumor cells or surrounding tissues. In situ hybridization (ISH) is a technique that detects specific RNA or DNA sequences within cells in tissue samples. This method helps evaluate gene expression patterns, chromosomal abnormalities, and copy number variations. Fluorescence in situ hybridization utilizes fluorescent probes for detection. Special staining techniques visualize specific cellular components or highlight certain structures within histological samples. Digital pathology offers significant advantages in terms of efficiency, accuracy, and collaboration potential, while IHC and ISH are crucial for understanding the molecular characteristics of tissues and detecting specific biomarkers. Special staining techniques provide additional insights into cellular structures not visible through conventional methods.

Indications: Exponential use of tissue diagnostics in the detection and characterization of numerous cancer types

Tissue diagnostics play a pivotal role in the early detection and characterization of breast cancer, allowing personalized therapies to improve patient outcomes. Techniques such as immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH) are widely used to identify hormone receptor status, guiding targeted therapy decisions. Identifying different subtypes of gastric cancer using tissue diagnostics assists clinicians with prognosis prediction and therapy selection. IHC is commonly employed to detect molecular biomarkers such as HER2 overexpression that directs the use of targeted therapies such as trastuzumab. Accurate diagnosis and subtyping of lymphoma are crucial for appropriate treatment planning since it comprises a heterogeneous group of malignancies involving immune system cells. Tissue diagnostic techniques can identify specific cell markers to differentiate between Hodgkin's and non-Hodgkin's lymphomas or even identify subtypes within these categories. Tissue diagnostics helps identify genetic alterations such as EGFR mutations, ALK rearrangements, and PD-L1 expression levels that can guide treatment decisions. Prostate cancer is the second most common cancer among men globally. Tissue diagnostics are crucial for determining the pathological grade of tumors through Gleason scoring and evaluating prognostic markers such as Ki-67 and PTEN loss.

End-User: Significant utilization of tissue diagnostics in clinical pathology laboratories to improve patient care quality

The primary need for tissue diagnostics in clinical pathology laboratories is to detect and diagnose various diseases at the molecular level. It helps pathologists identify biomarkers associated with specific diseases using techniques such as immunohistochemistry (IHC), in situ hybridization (ISH), and hematoxylin (H&E) staining. Contract research organizations (CROs) require tissue diagnostics services for preclinical and clinical research studies for pharmaceutical companies and biotechnology firms. These organizations prioritize cost-effectiveness, scalability, and turnaround times in choosing tissue diagnostic solutions. Tissue diagnostics are critical for patient diagnosis, treatment selection, and disease monitoring in hospital settings. Hospitals require reliable diagnostic solutions that provide accurate results with a minimal turnaround time to improve patient care quality while minimizing costs. Pharmaceutical companies utilize tissue diagnostics for drug development and clinical trials, necessitating solutions that identify target populations for precision medicine, optimize patient stratification, and evaluate treatment response in real-time. Academic and research institutions require cutting-edge tissue diagnostic solutions to investigate disease mechanisms, discover novel biomarkers, and advance therapeutic development. These laboratories prefer innovative technologies supporting high-throughput analysis and multiplexing capabilities.

Regional Insights

The Americas has a significant landscape in the tissue diagnostics market owing to advanced healthcare infrastructure and extensive research funding by the key manufacturers in the development of diagnostics tests. The manufacturers in the region have observed numerous patents issued by the FDA for innovations in tissue diagnostics technology. The EMEA region has observed a developing landscape in the tissue diagnostics market due to significant investments made by the government to support research initiatives for early diagnosis of diseases such as cancer to improve diagnostic techniques. Government standards and regulations on the safety and quality of tissue diagnostics consumables have also contributed to the market growth in the region. South Africa is a hub for innovation within the African continent, with several ongoing research initiatives focused on developing efficient diagnostic tools that cater to local disease prevalence patterns. APAC region in the market has a developing growth due to technological advancements, investment in research and development of state-of-the-art tissue diagnostic technologies, increasing cancer incidence, and government initiatives encouraging local manufacturing of diagnostic equipment, fostering innovation within the country's tissue diagnostics industry.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Tissue Diagnostics Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Tissue Diagnostics Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Tissue Diagnostics Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Abcam Plc, Agilent Technologies, Inc., Atlas Antibodies AB, Bio-Rad Laboratories, Inc., Bio-Techne Corporation, Biogenex Laboratories Inc., BioIVT, LLC, bioMerieux SA, Cardinal Health, Inc., Castle Biosciences, Inc., Cell Signaling Technology, Inc., Diagnostic BioSystems Inc., F. Hoffmann-La Roche Ltd, Leica Biosystems by Danaher Corporation, McKesson Corporation, Merck KGaA, MILESTONE MEDICAL Srl, PathAI, Inc., Pfizer Inc., PROGEN Biotechnik GmbH, QIAGEN N.V., Quest Diagnostics Incorporated, Sekisui Diagnostics, LLC, Siemens Healthineers AG, SLEE medical GmbH, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Tissue Diagnostics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Accessories
    • Consumables
      • Antibodies
      • Kits
      • Probes
      • Reagents
    • Instruments
      • Scanners
      • Slide-staining Systems
      • Tissue Microarrays
      • Tissue-processing Systems
    • Software
  • Technology
    • Digital Pathology & Workflow
    • Immunohistochemistry
    • In Situ Hybridization
    • Special Staining
  • Indications
    • Breast Cancer
    • Gastric Cancer
    • Lymphoma
    • Non Small Cell Lung Cancer
    • Prostate Cancer
  • End-User
    • Clinical Pathology
    • Contract Research Organization
    • Hospitals
    • Pharmaceutical Organizations
    • Research Laboratories
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Tissue Diagnostics Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Tissue Diagnostics Market?

3. What are the technology trends and regulatory frameworks in the Tissue Diagnostics Market?

4. What is the market share of the leading vendors in the Tissue Diagnostics Market?

5. Which modes and strategic moves are suitable for entering the Tissue Diagnostics Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing incidence of cancer worldwide
      • 5.1.1.2. Growing use of personalized medicine
      • 5.1.1.3. Government initiatives to increase awareness regarding effective and early cancer diagnosis
    • 5.1.2. Restraints
      • 5.1.2.1. High cost involved in tissue diagnosis and reimbursement issues
    • 5.1.3. Opportunities
      • 5.1.3.1. Inception of digital pathology and automated tissue diagnostics
      • 5.1.3.2. Innovative technologies and instruments development in tissue diagnostic field
    • 5.1.4. Challenges
      • 5.1.4.1. Limitations associated with tissue diagnostics procedures coupled with privacy concerns
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Proliferating use of tissue-processing systems for efficient processing and analyzing diagnosing tissue samples
    • 5.2.2. Technology: Adoption of digital pathology technology for the management of digitized histological samples through computer technology
    • 5.2.3. Indications: Exponential use of tissue diagnostics in the detection and characterization of numerous cancer types
    • 5.2.4. End-User: Significant utilization of tissue diagnostics in clinical pathology laboratories to improve patient care quality
  • 5.3. Market Trend Analysis
    • 5.3.1. Significant emphasis on securing approvals for tissue diagnostic technologies in the Americas
    • 5.3.2. Government initiatives to encourage early detection and screening of chronic diseases in the APAC region
    • 5.3.3. Revolutionary advancements in tissue diagnostic technologies in the EMEA region
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework Analysis

6. Tissue Diagnostics Market, by Product

  • 6.1. Introduction
  • 6.2. Accessories
  • 6.3. Consumables
  • 6.4. Instruments
  • 6.5. Software

7. Tissue Diagnostics Market, by Technology

  • 7.1. Introduction
  • 7.2. Digital Pathology & Workflow
  • 7.3. Immunohistochemistry
  • 7.4. In Situ Hybridization
  • 7.5. Special Staining

8. Tissue Diagnostics Market, by Indications

  • 8.1. Introduction
  • 8.2. Breast Cancer
  • 8.3. Gastric Cancer
  • 8.4. Lymphoma
  • 8.5. Non Small Cell Lung Cancer
  • 8.6. Prostate Cancer

9. Tissue Diagnostics Market, by End-User

  • 9.1. Introduction
  • 9.2. Clinical Pathology
  • 9.3. Contract Research Organization
  • 9.4. Hospitals
  • 9.5. Pharmaceutical Organizations
  • 9.6. Research Laboratories

10. Americas Tissue Diagnostics Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Tissue Diagnostics Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Tissue Diagnostics Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. PathAI Announces Expansion of BioPharma Lab to Provide End-to-End Central Pathology and Histology Services
    • 13.3.2. Ibex Raises USD 55 Million in Series C Funding to Drive Global Adoption of AI for Cancer Diagnosis
    • 13.3.3. Quest Diagnostics Launches Novel Prostate Cancer Test Aimed at Improving Diagnosis and Grading
    • 13.3.4. Cytelabs expanding diagnostic services to hospitals and patients across south India
    • 13.3.5. Bio-Techne Buys Lunaphore to Boost Cancer Diagnostics Through Spatial Biology
    • 13.3.6. Lunaphore Secures Chf 40 Million to Boost Portfolio of Tissue Diagnostics Solutions
    • 13.3.7. Launch of Optimer-Fc as a New Reagent Solution for Immunohistochemistry
    • 13.3.8. Ibex and Alverno Laboratories Sign Multi-Year, Multi-Tissue Expansion Agreement of AI for Cancer Diagnosis
    • 13.3.9. Roche Expands Collaboration with Janssen to Advance Personalized Healthcare Through Companion Diagnostics
    • 13.3.10. Guardant Health to Integrate Lunit's Ai-Based Scoring Algorithm for Pd-L1 into its Portfolio to Enhance Cancer Biomarker Detection
    • 13.3.11. Epredia and Aiforia Join RegenMed Hub Innovation Accelerator, Expanding PHC Group Presence in Regenerative Medicine Partnership Will Pave the Way for New RegenMed Clinical Trials Catalyst Program
    • 13.3.12. Microsoft Strikes Partnership with Paige to Advance Cancer Diagnostics and Treatment
    • 13.3.13. Agilent and Akoya Biosciences Announce Partnership to Drive Multiplex Tissue Assay Development for Biopharma Applications
    • 13.3.14. Tempus Receives U.S. FDA Approval for xT CDx, a NGS-Based In Vitro Diagnostic Device
    • 13.3.15. ROCHE tissue diagnostics celebrates marana expansion project

14. Competitive Portfolio

  • 14.1. Key Company Profiles
  • 14.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. TISSUE DIAGNOSTICS MARKET RESEARCH PROCESS
  • FIGURE 2. TISSUE DIAGNOSTICS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. TISSUE DIAGNOSTICS MARKET DYNAMICS
  • FIGURE 7. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 14. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS TISSUE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. AMERICAS TISSUE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES TISSUE DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 18. UNITED STATES TISSUE DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC TISSUE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC TISSUE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA TISSUE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA TISSUE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. TISSUE DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 24. TISSUE DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. TISSUE DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY ACCESSORIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY ACCESSORIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY ANTIBODIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY ANTIBODIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY KITS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY KITS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY PROBES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY PROBES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY REAGENTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY REAGENTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY SCANNERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY SCANNERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY SLIDE-STAINING SYSTEMS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY SLIDE-STAINING SYSTEMS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY TISSUE MICROARRAYS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY TISSUE MICROARRAYS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY TISSUE-PROCESSING SYSTEMS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY TISSUE-PROCESSING SYSTEMS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY SOFTWARE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY DIGITAL PATHOLOGY & WORKFLOW, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY DIGITAL PATHOLOGY & WORKFLOW, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY IN SITU HYBRIDIZATION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY IN SITU HYBRIDIZATION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY SPECIAL STAINING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY SPECIAL STAINING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 47. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 48. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 49. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 50. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY BREAST CANCER, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 51. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY GASTRIC CANCER, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 52. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY GASTRIC CANCER, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 53. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY LYMPHOMA, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 54. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY LYMPHOMA, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 55. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY NON SMALL CELL LUNG CANCER, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 56. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY NON SMALL CELL LUNG CANCER, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 57. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 58. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 59. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 60. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 61. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY CLINICAL PATHOLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 62. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY CLINICAL PATHOLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 63. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 64. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 65. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 66. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 67. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY PHARMACEUTICAL ORGANIZATIONS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 68. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY PHARMACEUTICAL ORGANIZATIONS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 69. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 70. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 71. AMERICAS TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 72. AMERICAS TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 73. AMERICAS TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
  • TABLE 74. AMERICAS TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
  • TABLE 75. AMERICAS TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 76. AMERICAS TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 77. AMERICAS TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 78. AMERICAS TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 79. AMERICAS TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 80. AMERICAS TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 81. AMERICAS TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 82. AMERICAS TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 83. AMERICAS TISSUE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 84. AMERICAS TISSUE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 85. ARGENTINA TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 86. ARGENTINA TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 87. ARGENTINA TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
  • TABLE 88. ARGENTINA TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
  • TABLE 89. ARGENTINA TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 90. ARGENTINA TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 91. ARGENTINA TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 92. ARGENTINA TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 93. ARGENTINA TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 94. ARGENTINA TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 95. ARGENTINA TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 96. ARGENTINA TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 97. BRAZIL TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 98. BRAZIL TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 99. BRAZIL TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
  • TABLE 100. BRAZIL TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
  • TABLE 101. BRAZIL TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 102. BRAZIL TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 103. BRAZIL TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 104. BRAZIL TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 105. BRAZIL TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 106. BRAZIL TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 107. BRAZIL TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 108. BRAZIL TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 109. CANADA TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 110. CANADA TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 111. CANADA TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
  • TABLE 112. CANADA TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
  • TABLE 113. CANADA TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 114. CANADA TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 115. CANADA TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 116. CANADA TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 117. CANADA TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 118. CANADA TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 119. CANADA TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 120. CANADA TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 121. MEXICO TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 122. MEXICO TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 123. MEXICO TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
  • TABLE 124. MEXICO TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
  • TABLE 125. MEXICO TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 126. MEXICO TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 127. MEXICO TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 128. MEXICO TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 129. MEXICO TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 130. MEXICO TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 131. MEXICO TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 132. MEXICO TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 133. UNITED STATES TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 134. UNITED STATES TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 135. UNITED STATES TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
  • TABLE 136. UNITED STATES TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
  • TABLE 137. UNITED STATES TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 138. UNITED STATES TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 139. UNITED STATES TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 140. UNITED STATES TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 141. UNITED STATES TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 142. UNITED STATES TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 143. UNITED STATES TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 144. UNITED STATES TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 145. UNITED STATES TISSUE DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 146. UNITED STATES TISSUE DIAGNOSTICS MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 147. ASIA-PACIFIC TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 148. ASIA-PACIFIC TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 149. ASIA-PACIFIC TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
  • TABLE 150. ASIA-PACIFIC TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
  • TABLE 151. ASIA-PACIFIC TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 152. ASIA-PACIFIC TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 153. ASIA-PACIFIC TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 154. ASIA-PACIFIC TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 155. ASIA-PACIFIC TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 156. ASIA-PACIFIC TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 158. ASIA-PACIFIC TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 159. ASIA-PACIFIC TISSUE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 160. ASIA-PACIFIC TISSUE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 161. AUSTRALIA TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 162. AUSTRALIA TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 163. AUSTRALIA TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
  • TABLE 164. AUSTRALIA TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
  • TABLE 165. AUSTRALIA TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 166. AUSTRALIA TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 167. AUSTRALIA TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 168. AUSTRALIA TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 169. AUSTRALIA TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 170. AUSTRALIA TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 171. AUSTRALIA TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 172. AUSTRALIA TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 173. CHINA TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 174. CHINA TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 175. CHINA TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
  • TABLE 176. CHINA TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
  • TABLE 177. CHINA TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 178. CHINA TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 179. CHINA TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 180. CHINA TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 181. CHINA TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 182. CHINA TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 183. CHINA TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 184. CHINA TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 185. INDIA TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 186. INDIA TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 187. INDIA TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
  • TABLE 188. INDIA TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
  • TABLE 189. INDIA TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 190. INDIA TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 191. INDIA TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 192. INDIA TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 193. INDIA TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 194. INDIA TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 195. INDIA TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 196. INDIA TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 197. INDONESIA TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 198. INDONESIA TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 199. INDONESIA TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
  • TABLE 200. INDONESIA TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
  • TABLE 201. INDONESIA TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 202. INDONESIA TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 203. INDONESIA TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 204. INDONESIA TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 205. INDONESIA TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 206. INDONESIA TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 207. INDONESIA TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 208. INDONESIA TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 209. JAPAN TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 210. JAPAN TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 211. JAPAN TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
  • TABLE 212. JAPAN TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
  • TABLE 213. JAPAN TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 214. JAPAN TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 215. JAPAN TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 216. JAPAN TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 217. JAPAN TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 218. JAPAN TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 219. JAPAN TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 220. JAPAN TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 221. MALAYSIA TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 222. MALAYSIA TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 223. MALAYSIA TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
  • TABLE 224. MALAYSIA TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
  • TABLE 225. MALAYSIA TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 226. MALAYSIA TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 227. MALAYSIA TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 228. MALAYSIA TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 229. MALAYSIA TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 230. MALAYSIA TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 231. MALAYSIA TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 232. MALAYSIA TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 233. PHILIPPINES TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 234. PHILIPPINES TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 235. PHILIPPINES TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
  • TABLE 236. PHILIPPINES TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
  • TABLE 237. PHILIPPINES TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 238. PHILIPPINES TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 239. PHILIPPINES TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 240. PHILIPPINES TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 241. PHILIPPINES TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 242. PHILIPPINES TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 243. PHILIPPINES TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 244. PHILIPPINES TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 245. SINGAPORE TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 246. SINGAPORE TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 247. SINGAPORE TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
  • TABLE 248. SINGAPORE TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
  • TABLE 249. SINGAPORE TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 250. SINGAPORE TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 251. SINGAPORE TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 252. SINGAPORE TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 253. SINGAPORE TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 254. SINGAPORE TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 255. SINGAPORE TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 256. SINGAPORE TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 257. SOUTH KOREA TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 258. SOUTH KOREA TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 259. SOUTH KOREA TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
  • TABLE 260. SOUTH KOREA TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
  • TABLE 261. SOUTH KOREA TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 262. SOUTH KOREA TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 263. SOUTH KOREA TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 264. SOUTH KOREA TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 265. SOUTH KOREA TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 266. SOUTH KOREA TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 267. SOUTH KOREA TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 268. SOUTH KOREA TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 269. TAIWAN TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 270. TAIWAN TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 271. TAIWAN TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
  • TABLE 272. TAIWAN TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
  • TABLE 273. TAIWAN TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 274. TAIWAN TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 275. TAIWAN TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 276. TAIWAN TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 277. TAIWAN TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 278. TAIWAN TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 279. TAIWAN TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 280. TAIWAN TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 281. THAILAND TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 282. THAILAND TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 283. THAILAND TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
  • TABLE 284. THAILAND TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
  • TABLE 285. THAILAND TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 286. THAILAND TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 287. THAILAND TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 288. THAILAND TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 289. THAILAND TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 290. THAILAND TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 291. THAILAND TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 292. THAILAND TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 293. VIETNAM TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 294. VIETNAM TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 295. VIETNAM TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
  • TABLE 296. VIETNAM TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
  • TABLE 297. VIETNAM TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 298. VIETNAM TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 299. VIETNAM TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 300. VIETNAM TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 301. VIETNAM TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 302. VIETNAM TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 303. VIETNAM TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 304. VIETNAM TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 305. EUROPE, MIDDLE EAST & AFRICA TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 306. EUROPE, MIDDLE EAST & AFRICA TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 307. EUROPE, MIDDLE EAST & AFRICA TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
  • TABLE 308. EUROPE, MIDDLE EAST & AFRICA TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
  • TABLE 309. EUROPE, MIDDLE EAST & AFRICA TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 310. EUROPE, MIDDLE EAST & AFRICA TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 311. EUROPE, MIDDLE EAST & AFRICA TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 312. EUROPE, MIDDLE EAST & AFRICA TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 313. EUROPE, MIDDLE EAST & AFRICA TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 314. EUROPE, MIDDLE EAST & AFRICA TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 315. EUROPE, MIDDLE EAST & AFRICA TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 316. EUROPE, MIDDLE EAST & AFRICA TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 317. EUROPE, MIDDLE EAST & AFRICA TISSUE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 318. EUROPE, MIDDLE EAST & AFRICA TISSUE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 319. DENMARK TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 320. DENMARK TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 321. DENMARK TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
  • TABLE 322. DENMARK TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
  • TABLE 323. DENMARK TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 324. DENMARK TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 325. DENMARK TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 326. DENMARK TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 327. DENMARK TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 328. DENMARK TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 329. DENMARK TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 330. DENMARK TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 331. EGYPT TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 332. EGYPT TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 333. EGYPT TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
  • TABLE 334. EGYPT TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
  • TABLE 335. EGYPT TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 336. EGYPT TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 337. EGYPT TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 338. EGYPT TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 339. EGYPT TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 340. EGYPT TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 341. EGYPT TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 342. EGYPT TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 343. FINLAND TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 344. FINLAND TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 345. FINLAND TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
  • TABLE 346. FINLAND TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
  • TABLE 347. FINLAND TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
  • TABLE 348. FINLAND TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
  • TABLE 349. FINLAND TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 350. FINLAND TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 351. FINLAND TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 352. FINLAND TISSUE DIAGNOSTICS MARKET SIZE, BY INDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 353. FINLAND TISSUE DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2023 (US